mortality/aging
• most LPS-treated mice die unlike wild-type mice
|
immune system
• in vesicular stomatitis virus-infected or poly(I:C)-injected mice
|
• in vesicular stomatitis virus- or Listeria monocytogenes-infected or poly(I:C)-injected mice
|
• in vesicular stomatitis virus- or Listeria monocytogenes-infected or poly(I:C)-injected mice
|
• in vesicular stomatitis virus-infected or poly(I:C)-injected mice
|
• in the spleen and liver of mice infected with Listeria monocytogenes
|
• in the spleen and liver of mice infected with Listeria monocytogenes
|
• most LPS-treated mice die unlike wild-type mice
|
• mice infected with Listeria monocytogenes exhibit reduced bacterial burden with increased IL6, IL12, CCL5, and CXCL10 levels in the serum, spleen and liver compared with wild-type mice
|
• most LPS-treated mice die unlike wild-type mice
|
• mice infected with vesicular stomatitis virus (VSV-GFP) exhibit fewer replicating viruses and elevated cytokines (IFN-beta, IL6, IL12 and TNF-alpha) compared with wild-type mice
|
homeostasis/metabolism
• in vesicular stomatitis virus-infected or poly(I:C)-injected mice
|
• in vesicular stomatitis virus- or Listeria monocytogenes-infected or poly(I:C)-injected mice
|
• in vesicular stomatitis virus- or Listeria monocytogenes-infected or poly(I:C)-injected mice
|
• in vesicular stomatitis virus-infected or poly(I:C)-injected mice
|